Vaccitech (VACC)
NASDAQ: VACC
· Real-Time Price · USD
5.00
0.51 (11.36%)
At close: Nov 06, 2023, 10:00 PM
Vaccitech Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|
| License Revenue | n/a | 14.97M | 300K | 468K | 6.46M | 16K | 16K | 16K |
| License Revenue Growth | -100.00% | +4889.67% | -35.90% | -92.75% | +40256.25% | 0.00% | 0.00% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.38M | 12.64M | 3.44M | 13.42M | 7.2M | 961K | 13.13M | 12.14M | 20.31M | -11.13M | -6.45M | 3.66M | 9.79M | 1.18M | 12.37M | 1.78M | 7.42M | 977K | 970K | 1.11M |
| Selling, General, and Administrative Revenue Growth | +21.72% | +267.09% | -74.34% | +86.36% | +649.32% | -92.68% | +8.16% | -40.23% | -282.43% | +72.72% | -275.95% | -62.57% | +726.52% | -90.43% | +596.17% | -76.06% | +659.64% | +0.72% | -12.77% | n/a |
| Research and Development Revenue | 7.95M | 8.29M | 6.66M | 11.14M | 11.66M | 13.94M | 12.98M | 8.66M | 12.1M | 10.47M | 8.89M | 9.65M | 5.67M | 3.41M | 3.63M | 3.65M | 2.28M | 2.09M | 3.2M | 3.54M |
| Research and Development Revenue Growth | -4.07% | +24.55% | -40.25% | -4.48% | -16.34% | +7.36% | +49.98% | -28.42% | +15.54% | +17.70% | -7.86% | +70.28% | +66.15% | -6.11% | -0.57% | +60.61% | +8.89% | -34.65% | -9.76% | n/a |